Biondo Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,328
Closed -$393K 85
2025
Q4
$393K Buy
6,328
+155
+3% +$9.57K 0.05% 81
2025
Q3
$371K Buy
6,173
+260
+4% +$15.9K 0.05% 82
2025
Q2
$370K Sell
5,913
-105
-2% -$6.31K 0.05% 81
2025
Q1
$362K Sell
6,018
-294
-5% -$18.3K 0.05% 77
2024
Q4
$368K Buy
6,312
+760
+14% +$45.2K 0.05% 76
2024
Q3
$329K Buy
5,552
+270
+5% +$15.4K 0.05% 78
2024
Q2
$296K Hold
5,282
0.04% 78
2024
Q1
$309K Buy
5,282
+290
+6% +$16.4K 0.05% 82
2023
Q4
$269K Buy
4,992
+51
+1% +$2.49K 0.05% 72
2023
Q3
$240K Buy
4,941
+215
+5% +$11.4K 0.05% 76
2023
Q2
$267K Buy
4,726
+620
+15% +$34.1K 0.05% 74
2023
Q1
$222K Buy
+4,106
New +$219K 0.04% 74

Other funds holding IHI

Biondo Investment Advisors's IHI Position: Q1 2026 in Review

Biondo Investment Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 6,328 shares — an estimated $393K sold.

Biondo Investment Advisors first reported a position in IHI in Q1 2023 and held it in 12 quarters. The position peaked at $393K in Q4 2025. 509 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Biondo Investment Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Biondo Investment Advisors sold 6,328 iShares US Medical Devices ETF shares in Q1 2026, an estimated $393K.
  • Biondo Investment Advisors first reported a position in iShares US Medical Devices ETF in Q1 2023 and held it in 12 quarters.
  • Biondo Investment Advisors's iShares US Medical Devices ETF position peaked at $393K in Q4 2025.
  • 509 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.